Matches in Nanopublications for { ?s ?p "[The objective of this study was to investigate whether tumor derived fibronectin alternatively spliced EDA domain has a lymphangiogenic potency on human lymphatic endothelial cells (LECs) in tumor generation to facilitate tumor lymphatic metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_assertion description "[The objective of this study was to investigate whether tumor derived fibronectin alternatively spliced EDA domain has a lymphangiogenic potency on human lymphatic endothelial cells (LECs) in tumor generation to facilitate tumor lymphatic metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_provenance.
- assertion description "[The objective of this study was to investigate whether tumor derived fibronectin alternatively spliced EDA domain has a lymphangiogenic potency on human lymphatic endothelial cells (LECs) in tumor generation to facilitate tumor lymphatic metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP409662.RAWNSkXO7vp25nh-vxbRKY6MwYCHuGPQ0Kodcaf0-7-NA130_assertion description "[The objective of this study was to investigate whether tumor derived fibronectin alternatively spliced EDA domain has a lymphangiogenic potency on human lymphatic endothelial cells (LECs) in tumor generation to facilitate tumor lymphatic metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP409662.RAWNSkXO7vp25nh-vxbRKY6MwYCHuGPQ0Kodcaf0-7-NA130_provenance.
- NP755585.RA3ug4FMua24ALU2Re0ZC2RhQFRkoNN5Ii5xPKefYlR2U130_assertion description "[The objective of this study was to investigate whether tumor derived fibronectin alternatively spliced EDA domain has a lymphangiogenic potency on human lymphatic endothelial cells (LECs) in tumor generation to facilitate tumor lymphatic metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755585.RA3ug4FMua24ALU2Re0ZC2RhQFRkoNN5Ii5xPKefYlR2U130_provenance.
- NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_assertion description "[The objective of this study was to investigate whether tumor derived fibronectin alternatively spliced EDA domain has a lymphangiogenic potency on human lymphatic endothelial cells (LECs) in tumor generation to facilitate tumor lymphatic metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_provenance.